Expression of CK19 in papillary thyroid carcinoma in comparison with benign thyroid lesions

Thura Abbas Fadhel
{"title":"Expression of CK19 in papillary thyroid carcinoma in comparison with benign thyroid lesions","authors":"Thura Abbas Fadhel","doi":"10.26505/djm.v24i1.972","DOIUrl":null,"url":null,"abstract":"Background: The Papillary variant of thyroid carcinoma is one of the common types of thyroid malignancies , the commonest. Its diagnosis  usually is microscopic which based on  nuclear features. \nObjective: To assess  the immunohistochemical  expression of cytokeratin 19 (CK19) in PTC and compare its reactivity with other thyroid conditions to approve its importance as a useful  test for diagnosing PTC. \nPatients and Methods: Twenty- cases of papillary thyroid carcinoma (with different variants), five follicular adenomas and ten multinodular goiters (MNG) were collected over three years (2018-2021).10% formalin-fixed sections were collected from thyroidectomy specimens. Stained with Hematoxylin and eosin  then  immunohistochemical  staining for  immune-marker CK 19 was done using standard techniques. The results were quantitatively scored as the following: score 0 (negative ), score 1+ (<5%) positive cells), score 2+ (5- 25%), score 3+ (25-75%) ,finally score 4+ (>75%) positive cells), and then calculated. \nResults: An 18 (90%) papillary carcinomas show diffuse and strong (3+ and 4+) expression of CK19 . ,three out of ten (30%) MNG were weakly positive(1+ and 2+) and focal in distribution while in  follicular adenoma all cases were negative for CK19 . \nConclusion: Ck 19 can stain benign and malignant thyroid tissue, but strong membranous staining applied  in cases of papillary ca , thus can be used as confirmatorytool for PTC diagnosis.","PeriodicalId":11202,"journal":{"name":"Diyala Journal of Medicine","volume":"90 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diyala Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26505/djm.v24i1.972","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Papillary variant of thyroid carcinoma is one of the common types of thyroid malignancies , the commonest. Its diagnosis  usually is microscopic which based on  nuclear features. Objective: To assess  the immunohistochemical  expression of cytokeratin 19 (CK19) in PTC and compare its reactivity with other thyroid conditions to approve its importance as a useful  test for diagnosing PTC. Patients and Methods: Twenty- cases of papillary thyroid carcinoma (with different variants), five follicular adenomas and ten multinodular goiters (MNG) were collected over three years (2018-2021).10% formalin-fixed sections were collected from thyroidectomy specimens. Stained with Hematoxylin and eosin  then  immunohistochemical  staining for  immune-marker CK 19 was done using standard techniques. The results were quantitatively scored as the following: score 0 (negative ), score 1+ (<5%) positive cells), score 2+ (5- 25%), score 3+ (25-75%) ,finally score 4+ (>75%) positive cells), and then calculated. Results: An 18 (90%) papillary carcinomas show diffuse and strong (3+ and 4+) expression of CK19 . ,three out of ten (30%) MNG were weakly positive(1+ and 2+) and focal in distribution while in  follicular adenoma all cases were negative for CK19 . Conclusion: Ck 19 can stain benign and malignant thyroid tissue, but strong membranous staining applied  in cases of papillary ca , thus can be used as confirmatorytool for PTC diagnosis.
CK19在甲状腺乳头状癌和甲状腺良性病变中的表达
背景:乳头状变型甲状腺癌是甲状腺恶性肿瘤中最常见的类型之一。它的诊断通常是基于核特征的显微诊断。目的:评价细胞角蛋白19 (cytokeratin 19, CK19)在PTC中的免疫组化表达,并将其与其他甲状腺疾病的反应性进行比较,以证实其作为诊断PTC的有效检测方法的重要性。患者与方法:2018-2021年共收集20例不同类型甲状腺乳头状癌、5例滤泡性腺瘤、10例多结节性甲状腺肿(MNG)。甲状腺切除术标本取10%福尔马林固定切片。用苏木精和伊红染色,然后用标准技术对免疫标记物ck19进行免疫组织化学染色。将结果定量评分为:0分(阴性),1分+(75%)阳性细胞),然后计算。结果:18例(90%)乳头状癌显示CK19的弥漫性和强表达(3+和4+)。3 / 10(30%)的MNG呈弱阳性(1+和2+)和局灶性分布,而滤泡性腺瘤均为CK19阴性。结论:Ck 19对甲状腺良恶性组织均有染色作用,但对乳头状癌有较强的膜性染色,可作为PTC诊断的确证工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信